David Lonbaken, DPM
Podiatrist · Pierre, SDNPI 1760458202
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Paragon 28, Inc. at 24.8% of the total. 2025 is the largest year on record at $358, more than ten times the $12 reported in 2019.
Across 43 payments — averaging $22.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$241
- Stryker$165
- E.r. Squibb & Sons, L.L.C.$124
- Lilly USA, LLC$109
- Mimedx Group, Inc.$53
- Exact Sciences$46
- plus $236 from 10 others
What the payments were for
- Food & beverage$973100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 4 | $241 |
| Stryker | 7 | $165 |
| E.r. Squibb & Sons, L.L.C. | 8 | $124 |
| Lilly USA, LLC | 6 | $109 |
| Mimedx Group, Inc. | 2 | $53 |
| Exact Sciences | 3 | $46 |
| Vertex | 2 | $31 |
| Smith+Nephew | 1 | $31 |
| Amgen | 2 | $30 |
| Novo Nordisk | 2 | $29 |
| Organogenesis Inc. | 1 | $25 |
| Medtronic | 1 | $22 |
| Merck | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Pfizer | 1 | $15 |
| Johnson & Johnson | 1 | $13 |
How this compares
Too few podiatrist providers in South Dakotato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $327 |
| Levofloxacin | 17 | $231 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $189 |
| Cephalexin | 23 | $180 |
| Doxycycline Hyclate | 19 | $176 |
| Allopurinol | 11 | $92 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Pierre
- Brian DixSioux Falls$48K
- Anthony DoyonRapid City$5K
- Rylan JohnsonRapid City$3K
- Jordan FinckHuron$2K
- Mark GraeberSioux Falls$1K
- Carolyn StansberrySpearfish$1K
- Michael McGowanSioux Falls$1K
- Chad StappAberdeen$711
- Kent RenaudRapid City$704
- Christine WiardaYankton$450
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.